CME Group
$265.10Change from previous close: +1.19%Absolute change: +$3.12
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 6,507 | 6,120 | 5,579 | 5,019 | 4,690 |
| Cost of revenue | 907 | 850 | 829 | 753 | — |
| Gross profit | 6,507 | 6,120 | 5,579 | 5,019 | 4,690 |
| Selling, general and administrative | 1,751 | 1,646 | 1,515 | 1,399 | 1,418 |
| Operating income | 4,259 | 3,937 | 3,458 | 3,003 | 2,605 |
| EBIT | 4,259 | 3,937 | 3,458 | 3,003 | 2,605 |
| EBITDA | 4,590 | 4,274 | 3,811 | 3,365 | 2,990 |
| Interest expense | 173 | 161 | 159 | 163 | 167 |
| Pre-tax income | 5,331 | 4,541 | 4,154 | 3,490 | 3,374 |
| Income tax | 1,258 | 1,016 | 927 | 799 | 737 |
| Net income | 4,072 | 3,526 | 3,226 | 2,691 | 2,636 |
| Net income to common shareholders | 4,021 | 3,482 | 3,186 | 2,657 | 2,617 |
| Basic EPS | 11.18 | 9.69 | 8.87 | 7.41 | 7.30 |
| Diluted EPS | 11.16 | 9.67 | 8.86 | 7.40 | 7.29 |
| Average shares (basic) | 360 | 359 | 359 | 359 | 358 |
| Average shares (diluted) | 360 | 360 | 360 | 359 | 359 |
| Dividend per share | 5.00 | 4.60 | 4.40 | 4.00 | 3.60 |